Oncology & Cancer

Zebrafish avatars can help tailor glioblastoma therapies

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study published in EMBO Molecular Medicine.

Oncology & Cancer

Testing transgenic T cells against malignant brain tumors

Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) have successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.

Oncology & Cancer

Scientists employ AI to predict brain cancer outcomes

Glioblastoma is a swift and aggressive brain cancer, with an average life expectancy of about one year after diagnosis. It's difficult to treat, in part because the cellular makeup of each tumor varies greatly from person ...

Diseases, Conditions, Syndromes

Consumer Health: What is glioblastoma?

More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and ...

page 2 from 25